Skip to main content
. 2022 Dec 8;13(2):825–834. doi: 10.21037/qims-22-307

Table 2. Right atrial volume-based functional properties in healthy cases with different maximum right atrial dimensions as assessed by three-dimensional speckle-tracking echocardiography.

Variables Vmax <30 mL (n=19) 30 mL ≤ Vmax ≤60 mL (n=129) Vmax >60 mL (n=31)
TASV (mL) 12.2±3.5 19.2±7.5* 33.6±9.6*
TASV-indexed (mL/m2) 6.5±2.1 10.4±4.3* 17.8±5.3*
TASV (males) (mL) 12.3±3.2 19.8±7.2* 35.3±7.6*
TASV-indexed (males) (mL/m2) 6.3±1.9 9.7±3.8* 17.6±3.8*
TASV (females) (mL) 12.0±4.3 18.5±7.8* 31.5±11.4*
TASV-indexed (females) (mL/m2) 7.0±2.4 11.0±4.6* 18.0±6.6*
PASV (mL) 7.6±3.9 11.9±6.0* 23.2±9.6*
PASV-indexed (mL/m2) 4.1±2.0 6.4±3.3* 12.5±5.3*
PASV (males) (mL) 8.0±3.8 12.6±5.8* 23.7±9.2*
PASV-indexed (males) (mL/m2) 4.2±1.8 6.1±3.0 12.1±4.9*
PASV (females) (mL) 6.8±4.3 11.2±6.2 22.6±10.4*
PASV-indexed (females) (mL/m2) 4.0±2.5 6.7±3.6 12.9±6.0*
AASV (mL) 4.7±2.1 7.3±4.4* 10.3±5.2*
AASV-indexed (mL/m2) 2.4±1.3 4.0±2.6* 5.3±2.7*
AASV (males) (mL) 4.4±2.5 7.3±4.3* 11.6±5.7*
AASV-indexed (males) (mL/m2) 2.1±1.5 3.7±2.3* 5.5±3.0*
AASV (females) (mL) 5.2±0.9 7.3±4.4 8.9±4.1*
AASV-indexed (females) (mL/m2) 3.0±0.6 4.3±2.8 5.0±2.4
TAEF (%) 46.1±12.2 43.0±13.9 47.1±11.6
TAEF (males) (%) 47.6±11.0 44.6±13.6 49.0±10.5
TAEF (females) (%) 42.9±15.0 41.5±14.2 44.7±12.8
PAEF (%) 28.9±15.1 26.5±12.2 32.5±12.6
PAEF (males) (%) 31.0±15.2 28.0±11.8 32.9±12.4
PAEF (females) (%) 24.3±15.3 25.1±12.5 32.0±13.3
AAEF (%) 23.9±7.9 22.7±12.5 21.6±9.3
AAEF (males) (%) 23.3±8.9 23.3±12.6 23.8±10.5
AAEF (females) (%) 25.3±5.6 22.2±12.4 18.8±7.1

Data are presented as mean ± standard deviation. *, P<0.05 vs. Vmax <30 mL; , P<0.05 vs. 30 mL ≤ Vmax ≤60 mL. Vmax, maximum right atrial volume; AASV, active atrial stroke volume; PASV, passive atrial stroke volume; TASV, total atrial stroke volume; AAEF, active atrial emptying fraction; PAEF, passive atrial emptying fraction; TAEF, total atrial emptying fraction.